ENDPOINTS

BridgeBio, Editas finance chiefs depart; Former FDA No. 2 joins Recursion's board

→ Brian Stephenson has stepped down after more than five years as CFO of BridgeBio, and president Tom Trimarchi will take over. Trimarchi was promoted to president and COO last July. “It has been an ...

Mar 21, 2025 - 12:05
 0
BridgeBio, Editas finance chiefs depart; Former FDA No. 2 joins Recursion's board
→ Brian Stephenson has stepped down after more than five years as CFO of BridgeBio, and president Tom Trimarchi will take over. Trimarchi was promoted to president and COO last July. “It has been an ...
Read More

Tags:

Previous Article

Exclusive: VantAI's builds AI model Neo-1 for molecular glues

Next Article

Chennai’s blueprint for heat-resistant homes

Related Posts

Endo sells international business for $84M

Endo sells international business for $84M

Mar 11, 2025  0

CHMP recommends Regeneron, Novartis drugs that still await FDA approval

CHMP recommends Regeneron, Novartis drugs that still aw...

Feb 28, 2025  0

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Senators ask FDA to dig into 'misleading' Super Bowl ad...

Feb 9, 2025  0